Reference
Gupta R, et al. The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States. Journal of Managed Care and Specialty Pharmacy 23: 1066-76, No. 10, Oct 2017. Available from: URL: https://doi.org/10.18553/jmcp.2017.23.10.1066
Rights and permissions
About this article
Cite this article
Unintended consequence of FDA's regulation of unapproved drugs. PharmacoEcon Outcomes News 789, 31 (2017). https://doi.org/10.1007/s40274-017-4438-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4438-1